-+ 0.00%
-+ 0.00%
-+ 0.00%

GRAIL PRESENTS PATHFINDER 2 RESULTS OF MORE THAN 35,000 PARTICIPANTS SHOWING THE GALLERI® TEST SUBSTANTIALLY INCREASED CANCER DETECTION WITH ROBUST PERFORMANCE AND FAVORABLE SAFETY AT 2026 ASCO ANNUAL MEETING

Reuters·05/31/2026 12:00:01

Please log in to view news